DePuy ASR hip implant lawsuit MDL 2197: how the $2.5 billion settlement framework actually works and the post-2013 revision surgery framework

The DePuy ASR hip implant litigation under MDL 2197 (In re: DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation), pending in the U.S. District Court for the Northern District of Ohio before Judge Jeffrey J. Helmick (succeeding Judge David Katz), represents one of the most substantially-resolved metal-on-metal hip implant mass torts. The substantial settlement framework reached in November 2013 provided approximately $2.5 billion for approximately 8,000 patients with base awards of $250,000 per qualifying plaintiff plus substantial enhancements based on age, medical complications, and other factors. The settlement expanded in March 2015 to cover revisions after August 31, 2013. Total Johnson & Johnson and DePuy hip implant settlements across the ASR products and the related DePuy Pinnacle products exceed $4 billion across approximately 20,000 separate claims. Approximately 119 lawsuits remain pending in MDL 2197 as of April 2026 — substantially reduced from the peak case count but still providing framework for individual claims.

The substantive theory centers on the design defects of the DePuy ASR (Articular Surface Replacement) products — metal-on-metal hip implant systems introduced in the early-to-mid 2000s. The products at issue include the DePuy ASR XL Acetabular Hip System (a total hip replacement system) and the DePuy ASR Hip Resurfacing System (a hip resurfacing system that was never approved for U.S. sale but was implanted in numerous patients outside the U.S. and substantially marketed worldwide). The metal-on-metal design produced substantial metal debris (chromium and cobalt ions) through articulation between the metal femoral head and metal acetabular cup — substantially shedding metal particles into surrounding tissue and into the bloodstream. The substantial metal debris caused metallosis (tissue damage from metal ions), substantial necrosis of surrounding tissue, substantial loosening of the implant, substantial pain and decreased range of motion, substantial bone loss around the implant, and substantial systemic effects from elevated blood metal levels. The substantial defective design produced substantial early revision surgery requirements that substantially exceeded expectations for hip implant products.

The procedural history of MDL 2197 illustrates the substantial framework for metal-on-metal hip implant litigation. DePuy issued a worldwide recall of the ASR products in August 2010 after substantial revision surgery rates emerged in registry data. The substantial revision rate was approximately 12-13% within 5 years of implantation — substantially exceeding the typical 1-2% revision rate for traditional hip implant products. The November 2013 settlement framework established the substantial procedural template for metal-on-metal hip implant resolution — base awards plus enhancements based on substantial individual factors. The substantial March 2015 expansion extended coverage to revisions after August 31, 2013. The continuing 119 cases pending in MDL 2197 as of April 2026 substantially represent cases that either didn't fit the settlement framework or substantially complex individual situations requiring substantial individual evaluation.

This is how the DePuy ASR hip implant litigation actually works through MDL 2197, the substantive theory of metal-on-metal hip implant design defects, the substantial settlement framework with $250,000 base awards plus enhancements, the substantial procedural framework for the post-2013 revision surgery framework, the substantial eligibility analysis for prospective plaintiffs, and the strategic considerations for affected patients pursuing claims through the substantial framework.

What the DePuy ASR products are and the alleged defects

The DePuy ASR products are specific metal-on-metal hip implant systems:

DePuy ASR XL Acetabular Hip System:

Total hip replacement system
Metal-on-metal articulation
Substantial market introduction (early-to-mid 2000s)
Substantial product line
August 2010 recall
Substantial implantation in U.S. and worldwide

DePuy ASR Hip Resurfacing System:

Hip resurfacing system (not full replacement)
Metal-on-metal articulation
Substantial market introduction
Never approved for U.S. sale (substantial)
Substantially implanted outside U.S.
August 2010 worldwide recall

Metal-on-metal design. Substantial:

Metal femoral head articulating against metal acetabular cup
Substantial mechanical concept (versus metal-on-polyethylene or ceramic-on-ceramic)
Substantial design intent: durability for younger patients
Substantial actual failure pattern

Alleged design defects:

Substantial metal debris generation. Substantial:

Articulation produces metal particles
Chromium and cobalt ions
Substantial particle generation rate
Substantial design-inherent issue

Substantial metallosis. Substantial:

Tissue damage from metal ions
Substantial inflammation
Substantial soft tissue necrosis
Substantial bone loss
Substantial systemic effects

Substantial component loosening. Substantial:

Bone-implant interface failure
Substantial revision requirement
Substantial pain
Substantial functional limitation

Substantial early revision rate. Substantial:

12-13% within 5 years (per registry data)
Vs typical 1-2% for traditional hip implants
Substantial design defect indicator
Substantial recall trigger

Substantial systemic effects. Substantial:

Elevated blood chromium levels
Elevated blood cobalt levels
Substantial neurological effects (some patients)
Substantial cardiac effects (some patients)
Substantial thyroid effects (some patients)
Substantial systemic health implications

The alleged injuries

Plaintiffs in MDL 2197 allege various injuries:

Substantial revision surgery requirement. Substantial:

Earlier than expected revision
Substantial surgical complications
Substantial recovery period
Substantial functional impact

Substantial metallosis. Substantial:

Tissue damage from metal ions
Substantial inflammation
Soft tissue necrosis
Bone loss
Substantial revision surgery complications

Substantial pain and limited mobility. Substantial:

Hip pain
Groin pain
Substantial decreased range of motion
Substantial functional limitation

Substantial bone loss around implant. Substantial:

Osteolysis from metal debris
Substantial revision surgery complications
Substantial bone reconstruction requirements
Substantial procedural complexity

Substantial elevated blood metal levels. Substantial:

Chromium toxicity
Cobalt toxicity
Substantial systemic effects
Substantial monitoring requirements

Substantial pseudotumor formation. Substantial:

Substantial mass-like collections from metal reaction
Substantial surgical intervention required
Substantial complications

Substantial systemic health effects. Substantial:

Cardiomyopathy
Neurological effects
Thyroid effects
Visual effects
Substantial individual health impact

Substantial wrongful death cases. Some:

Cardiac complications
Substantial systemic effects
Substantial wrongful death framework
Substantial state law variation

The procedural history of MDL 2197

The litigation has developed through several phases:

2005-2010. Substantial market introduction of ASR products. Substantial registry data accumulation showing concerning revision rates.

August 24, 2010. DePuy issues worldwide recall of:

ASR XL Acetabular Hip System
ASR Hip Resurfacing System
Substantial regulatory action

Late 2010-2011. Substantial lawsuit filing across multiple jurisdictions.

December 2010. Judicial Panel on Multidistrict Litigation establishes MDL 2197 in N.D. Ohio. Judge David Katz initially assigned.

2011-2013. Substantial discovery and motion practice. Substantial individual case development.

November 19, 2013. Substantial settlement framework reached:

$2.5 billion total
Approximately 8,000 patients
$250,000 base award per plaintiff
Enhanced awards for substantial complications
Eligible: ASR patients who had revision surgery to replace ASR XL Acetabular Hip System or ASR Hip Resurfacing System on or before August 31, 2013

March 2015. Settlement framework expanded:

Revisions after August 31, 2013 covered
Substantial procedural framework continuation
Substantial subsequent cases included

2016-2020. Substantial individual case processing and settlement administration through BrownGreer as settlement administrator.

2020-2024. Continued individual cases for plaintiffs not within original settlement framework. Substantial individual case evaluation.

Judge transition. Substantial:

Judge David Katz initially
Judge Jeffrey J. Helmick subsequently
Substantial procedural continuation

April 2026. 119 pending cases in MDL 2197:

Substantially reduced from peak
Substantial individual case framework
Substantial procedural continuation
Substantial settlement framework reference

The substantial settlement framework

The November 2013 settlement provided:

Base awards

Substantial base award: $250,000 per qualifying plaintiff.

Substantial substantive framework:

Standard base for qualifying cases
Substantial procedural framework
Substantial individual case analysis
Substantial settlement administration

Enhancement framework

Substantial enhancements available for:

Patient age. Substantial:

Younger patients (substantial impact on longevity)
Substantial individual factor
Substantial enhancement framework

Medical complications. Substantial:

Substantial individual factors
Substantial enhancement framework
Substantial individual case evaluation

Substantial revision surgery complications:

Substantial subsequent surgeries
Substantial complications
Substantial enhancement framework

Substantial systemic health effects:

Cardiac complications
Neurological complications
Substantial systemic effects
Substantial enhancement framework

Multiple revision surgeries. Substantial:

Each additional revision substantial
Substantial enhancement framework
Substantial individual factor

Substantial wage loss and disability. Substantial:

Lost income
Future earning capacity
Substantial enhancement framework

Substantial reduction framework

Substantial reductions for:

Substantial substantive factors that may reduce base award. Substantial:

Substantial individual factors
Substantial case-by-case evaluation
Substantial procedural framework

Settlement administration

Substantial procedural framework:

BrownGreer LLP as settlement administrator:

Substantial procedural administration
Substantial documentation framework
Substantial individual case evaluation
Substantial procedural compliance

Substantial procedural requirements:

Medical records
Substantial documentation
Substantial procedural framework
Substantial professional involvement valuable

Post-2013 framework for non-settlement cases

For substantial cases outside settlement framework:

Substantial individual case framework

Substantial procedural framework:

Individual case evaluation
Substantial procedural complexity
Substantial professional involvement valuable
Substantial framework continuation

Substantial individual case factors

Substantial individual factors:

Specific injury severity
Specific complications
Specific medical history
Substantial state law factors
Substantial procedural framework

Substantial state court alternatives

Substantial state court framework:

Some cases pursued in state courts
Substantial individual analysis
Substantial procedural framework
Substantial state-specific law

Eligibility framework

For prospective plaintiffs:

Documenting DePuy ASR implantation

Critical first step. Identify specific product:

Surgical records (operative report)
Hospital records identifying specific implant
Manufacturer identification (DePuy specifically)
Product model identification (ASR XL Acetabular or ASR Hip Resurfacing)
Lot numbers and serial numbers
Substantial product-specific identification

Important note. Many hip implant products in market:

DePuy ASR (this MDL — settled)
DePuy Pinnacle (separate MDL 2244, also largely settled)
Stryker LFIT V40, ABG II, Rejuvenate, Tritanium (separate MDLs)
Wright Profemur (separate MDL)
Smith & Nephew Birmingham Hip Resurfacing (some litigation)
Zimmer products (various)
Various other manufacturer products

The specific manufacturer determines which litigation framework applies.

Documenting the injury

Strong case requirements:

Imaging documentation:

X-rays showing implant
CT scans showing complications
MRI MARS (Metal Artifact Reduction Sequence) for soft tissue evaluation
Substantial radiological evidence

Specific injury types:

Revision surgery requirement
Metallosis
Soft tissue necrosis
Bone loss (osteolysis)
Elevated blood metal levels
Pseudotumor formation
Substantial systemic effects

Treatment records:

Revision surgery records
Complications during revision
Subsequent medical treatment
Pain management
Functional limitations

Substantial connection to ASR implant:

Medical evaluation supporting causation
Treating physician statements
Pathology of removed implant
Substantial documentation of connection

Statute of limitations analysis

Most states have 2-4 year limitations from injury or discovery:

Discovery rule may apply
Substantial individual variation
Specific state law analysis required
Some delayed discovery cases viable
Substantial counsel evaluation needed

Substantial DePuy statute of limitations defenses raised. DePuy substantially:

Raises statute of limitations as defense
Substantial individual analysis required
Substantial counsel involvement valuable

How DePuy ASR litigation compares to other mass torts

The litigation has distinctive features:

Compared to Stryker hip implant MDLs: Both involve hip implant litigation. Stryker LFIT V40 MDL 2768 settled for $75 million; ABG II/Rejuvenate MDL 2441 settled for $1.4 billion; DePuy ASR settled for $2.5 billion. Different metal-on-metal vs taper junction defect theories.

Compared to Cook IVC filter MDL 2570: Both involve medical device litigation. Cook has partial settlement framework; DePuy ASR substantially settled in 2013-2015.

Compared to Bard IVC filter MDL 2641: Both involve substantially settled medical device litigation. Bard IVC settled May 2019; DePuy ASR settled November 2013.

Compared to Bard hernia mesh MDL 2846: Both involve substantial medical device settlements. Bard hernia mesh reached $1+ billion settlement; DePuy ASR reached $2.5 billion.

Compared to Bair Hugger MDL 2666: Both involve joint replacement-related litigation. Bair Hugger involves infections related to surgery; DePuy ASR involves the implant device itself.

Compared to Exactech device recall MDL 3044: Both involve orthopedic device defects. Exactech faces bankruptcy complications; DePuy/J&J had substantial financial capacity for $2.5 billion settlement.

Distinctive DePuy ASR features:

Mature MDL (15+ years)
Substantially settled (November 2013, expanded March 2015)
$2.5 billion settlement framework
$250,000 base award per qualifying plaintiff
Substantial enhancement framework
8,000 patients in original settlement
119 cases pending as of April 2026
Substantial metal-on-metal design theory
August 2010 worldwide recall
BrownGreer administering settlement
DePuy ASR XL Acetabular AND ASR Hip Resurfacing System
Substantial systemic health effects framework
DePuy/J&J total hip product settlements: $4+ billion

Settlement projections

Settlement valuation varies substantially:

Cases within original settlement framework:

$250,000 base award
Substantial enhancements
Substantial procedural framework

Cases requiring individual evaluation:

Substantial individual factors
Substantial range of outcomes
Substantial procedural complexity

Estimated settlement ranges for post-2013 individual cases (varies substantially):

Severe complication cases:

Multiple revisions
Substantial systemic effects
Substantial bone loss
Range: $500,000 - $5,000,000+
Wrongful death cases potentially higher

Moderate complication cases:

Single revision
Substantial complications
Substantial functional impact
Range: $250,000 - $1,000,000

Less severe cases:

Revision required
Limited subsequent complications
Substantial documented harm
Range: $100,000 - $500,000

Wrongful death cases:

Substantial state law variation
Range varies dramatically by state
Substantial individual case factors

Tax implications. Personal injury settlements for physical injuries are tax-free under IRC §104(a)(2). Coordinate with tax counsel for substantial settlements, particularly when other tax debt issues or §72(t) early withdrawal considerations exist.

Strategic considerations

For affected patients and prospective plaintiffs:

Identify DePuy ASR implantation specifically. Critical first step:

Surgical records
Hospital identification
Manufacturer verification (DePuy specifically)
Product model identification (ASR XL Acetabular or ASR Hip Resurfacing)
Distinguish from Stryker, Wright, or other manufacturer products
Substantial documentation requirement

Document the injury comprehensively. Strong cases include:

Imaging studies (X-ray, CT, MRI MARS)
Treatment records
Revision surgery records
Pathology of removed implant
Treating physician opinions
Blood metal level testing
Functional impact documentation

Address the statute of limitations carefully. DePuy raises substantial defenses:

2-4 year periods in most states
Discovery rule applicability
Specific state law analysis
Some delayed discovery cases viable
Substantial counsel evaluation needed

Engage experienced hip implant counsel. Substantial procedural complexity:

Post-MDL settlement framework
Substantial procedural framework
Statute of limitations defenses
Settlement administration navigation
Substantial firm-specific DePuy experience valuable

Consider settlement participation if eligible. Substantial framework:

Original settlement framework
March 2015 expansion
BrownGreer settlement administration
Substantial procedural protection
Substantial timely resolution

Plan for extended timeline if individual case. Even within settlement framework:

Individual case evaluation
Substantial time investment
Substantial documentation requirement
Substantial wait for resolution

Document subsequent medical treatment. Strong cases include:

All medical care related to implant
Revision surgery documentation
Complication treatment
Ongoing pain management
Functional impact

Coordinate with treating physicians. Orthopedic surgeons and other treating physicians are important witnesses. Their assessment of causation strengthens cases.

Plan for the substantial growth loss when accessing retirement funds. Some plaintiffs:

Need retirement funds for medical expenses
§72(t) early withdrawal substantial cost
Substantial coordination required
May benefit from medical expense exception

Address related tax planning. Personal injury settlements for physical injuries are tax-free. Coordinate with tax counsel for substantial settlements. Component allocation (physical injury vs. emotional distress) affects tax treatment.

Watch the wrongful death framework. Some severe cases:

Cardiac complications from metal toxicity
Substantial systemic effects
Substantial state law variation
Estate has standing
Surviving family members may have separate claims

Document the lifestyle impact. Strong cases show:

Pre-implantation functional baseline
Loss of function post-implantation
Inability to return to work
Recreational activity loss
Daily life impact

Don't accept inadequate settlement offers without thorough evaluation. Many cases:

Substantial injury justifies more than initial offers
Negotiate based on documented damages
Consider individual trial if settlement insufficient
Substantial bellwether verdicts provide leverage

Plan for individual trial possibility. Some cases:

May proceed to individual MDL or state court trial
Substantial trial preparation
Substantial damages potential

Consider medical monitoring component. Even after settlement:

Ongoing surveillance for complications
Blood metal level monitoring
Long-term medical care
Future medical expenses
Substantial ongoing considerations

Address the multiple hip implant manufacturer landscape carefully. Many hip implant manufacturers:

DePuy ASR (this litigation)
DePuy Pinnacle (MDL 2244, separate)
Stryker LFIT V40, ABG II, Rejuvenate (separate MDLs)
Wright Profemur (separate)
Smith & Nephew BHR (some litigation)
Zimmer (various)

Identify specific manufacturer; substantial different procedural framework for each.

Watch for the metal-on-metal issue. Substantial pattern:

Metal-on-metal hip implants substantially associated with metal toxicity
Substantial systemic effects framework
Substantial complication risk increase
Substantial monitoring requirements

Coordinate with LLC asset protection if substantial business assets at risk. Substantial settlements may affect:

Business asset planning
Estate planning
Substantial coordination required

Use the substantial settlement precedent. Substantial leverage:

$2.5 billion settlement framework
$250,000 base award framework
Substantial enhancement framework
Substantial individual case framework

Plan for the substantial post-settlement framework. Substantial:

Individual cases continue
Substantial procedural framework
Substantial professional involvement valuable
Substantial state-specific law

Address the time-sensitive nature. Substantial:

Statute of limitations running
Substantial individual deadlines
Substantial counsel evaluation needed
Substantial procedural framework

Watch for related Stryker hip implant litigation: Substantial:

Similar device categories
Substantial similar issues
Substantial coordination considerations

Plan for the substantial DePuy/J&J corporate framework. Substantial:

$4+ billion total hip product settlements
Substantial corporate financial capacity
Substantial settlement framework continuation
Substantial procedural framework

Document substantial blood metal levels:

Chromium levels
Cobalt levels
Substantial systemic health monitoring
Substantial procedural framework

Plan substantial systemic health evaluation:

Cardiac evaluation
Neurological evaluation
Thyroid evaluation
Substantial individual analysis
Substantial procedural framework

Watch substantial recall implications:

August 2010 recall
Substantial regulatory framework
Substantial individual notification
Substantial procedural framework

Address substantial revision surgery documentation:

Surgical reports
Pathology of removed implant
Substantial medical documentation
Substantial procedural framework

Coordinate with substantial state court alternatives:

Some plaintiffs may benefit
Substantial individual analysis
Substantial procedural framework
Substantial counsel coordination

For affected patients with documented DePuy ASR hip implant injuries, the framework provides substantial paths to compensation through the substantial settled MDL 2197 framework (November 2013 settlement with $250,000 base awards and substantial enhancements, expanded March 2015 to cover revisions after August 31, 2013, $2.5 billion total settlement covering ~8,000 patients), the substantial subsequent settlement administration through BrownGreer, and the substantial individual case framework continuing for plaintiffs outside the original settlement. The substantial DePuy/J&J total hip product settlements of $4+ billion across approximately 20,000 separate claims demonstrate the substantial financial framework available for affected patients. The work for plaintiffs is in comprehensive product identification through surgical records (verifying specifically DePuy ASR rather than Stryker, Wright, Smith & Nephew, or another manufacturer, and identifying the specific product model — ASR XL Acetabular or ASR Hip Resurfacing System), thorough injury documentation including imaging studies (X-ray, CT, MRI MARS) and revision surgery records, blood metal level documentation for substantial systemic effects evidence, engagement with experienced hip implant counsel familiar with the substantial post-MDL settlement framework and the substantial statute of limitations issues, and patient navigation of the procedural complexity through either settlement participation or individual case framework. For plaintiffs with strong documented DePuy ASR complications — particularly those involving multiple revision surgeries, substantial systemic health effects from chromium and cobalt toxicity, substantial bone loss requiring complex reconstruction, or wrongful death situations — the litigation provides paths to meaningful compensation through the substantial established settlement framework with enhancements and the substantial individual case framework for cases requiring substantial individual evaluation.